Random forests to predict survival of octogenarians with brain metastases from nonsmall-cell lung cancer

被引:0
|
作者
Lijun Song [1 ]
Yu Wang [2 ]
Xue Li [3 ]
Yi Liu [3 ]
Bingyi Yin [3 ]
Daorui Li [3 ]
Hongsheng Lin [3 ]
Yuqi Zhang [1 ]
机构
[1] Department of Neurosurgery, Yuquan Hospital, Tsinghua University
[2] Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University
[3] Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences
关键词
D O I
暂无
中图分类号
R734.2 [肺肿瘤]; TP181 [自动推理、机器学习];
学科分类号
摘要
Background: To create and validate nomograms for the personalized prediction of survival in octogenarians with newly diagnosed nonsmall-cell lung cancer(NSCLC) with sole brain metastases(BMs). Methods: Random forests(RF) were applied to identify independent prognostic factors for building nomogram models. The predictive accuracy of the model was evaluated based on the receiver operating characteristic(ROC) curve, C-index, and calibration plots. Results: The area under the curve(AUC) values for overall survival at 6, 12, and 18 months in the validation cohort were 0.837, 0.867, and 0.849, respectively; the AUC values for cancer-specific survival prediction were 0.819, 0.835, and 0.818, respectively. The calibration curves visualized the accuracy of the model. Conclusion: The new nomograms have good predictive power for survival among octogenarians with sole BMs related to NSCLC.
引用
收藏
页码:39 / 56
页数:18
相关论文
共 50 条
  • [31] Combined modality treatment for locally advanced nonsmall-cell lung cancer
    Kelly, K
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (04) : 349 - 356
  • [32] Brain and leptomeningeal metastases in nonsmall cell lung cancer (NSCLC) responsive to Gefitinib
    Milton, DT
    Omuro, AMP
    Shah, N
    Franceschi, E
    Abrey, LE
    Miller, VA
    Kris, MG
    LUNG CANCER, 2004, 46 : S51 - S51
  • [33] Racial Disparities and Survival for Nonsmall-Cell Lung Cancer in a Large Cohort of Black and White Elderly Patients
    Hardy, Dale
    Xia, Rui
    Liu, Chih-Chin
    Cormier, Janice N.
    Nurgalieva, Zhannat
    Du, Xianglin L.
    CANCER, 2009, 115 (20) : 4807 - 4818
  • [34] Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
    Gong, Juejun
    Zhang, Li
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 55 - 58
  • [35] Maintenance Therapy in Nonsmall-Cell Lung Cancer A New Treatment Paradigm
    Mok, Tony S. K.
    Ramalingam, Suresh S.
    CANCER, 2009, 115 (22) : 5143 - 5154
  • [36] No Somatic Genetic Change in the Paxillin Gene in Nonsmall-Cell Lung Cancer
    Pallier, Karine
    Houllier, Anne-Marie
    Le Corre, Delphine
    Cazes, Aurelie
    Laurent-Puig, Pierre
    Blons, Helene
    MOLECULAR CARCINOGENESIS, 2009, 48 (07) : 581 - 585
  • [37] Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with nonsmall-cell lung cancer with actionable genetic alterations
    Jun, Soojin
    Jung, Hyun Ae
    Ahn, Myung-Ju
    Ahn, JinSeok
    Lee, Se-Hoon
    Sun, Jong Mu
    Park, Sehhoon
    Cho, Juhee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Identification of multiple cardiac metastases from nonsmall-cell lung cancer by 18F-FDG PET/CT A case report
    Deng, Shengming
    Zhang, Bin
    Li, Jihui
    Sang, Shibiao
    Zhang, Wei
    MEDICINE, 2018, 97 (49)
  • [39] Patterns of Whole Brain Radiation Therapy for Nonsmall Cell Lung Cancer Patients with Brain Metastases
    Rich, Shayna
    Dharmarajan, Kavita
    Rahman, Omari-Khalid
    Robbins, Jared
    Johnstone, Candice
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (02) : 455 - +
  • [40] Time for Reappraisal of Extracranial Treatment Options? Synchronous Brain Metastases From Nonsmall Cell Lung Cancer
    Lind, Joline S. W.
    Lagerwaard, Frank J.
    Smit, Egbert F.
    Postmus, Pieter E.
    Slotman, Ben J.
    Senan, Suresh
    CANCER, 2011, 117 (03) : 597 - 605